"US Biomarkers, Inc. - Product Pipeline Analysis, 2013 Update" Now Available at Fast Market Research
US Biomarkers, Inc. (US Biomarkers) is a molecular diagnostics company. The company provides disease-specific biomarkers for cancer and neurodegenerative diseases using DNA methylation. It has technology platform for DNA methylation discovery in ultra-small samples. US Biomarkers's MethDet technology is built on selective destruction of unmethylated fragments by a methylation-sensitive restriction enzyme. This technology analyzes DNA methylation on a genome-wide scale using ultra-small samples. The company's technology platform is also used in screening and differential diagnostics, companion diagnostics and prognostic and...
View full press release